Please ensure Javascript is enabled for purposes of website accessibility

Why Aurora Cannabis, Cronos Group, HEXO, OrganiGram Holdings, and Tilray Are Getting Hammered Today

By George Budwell – Feb 27, 2020 at 11:19AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Worries about the global supply chain are sinking these five Canadian pot stocks today.

What happened

Canadian pot stocks simply can't catch a break. After a tough year that saw Health Canada fail to license enough brick-and-mortar retail locations, which markedly hurt sales of dried flower products, the industry is getting absolutely walloped yet again today by the COVID-19 threat.

As of 10:30 a.m. EST Thursday, shares of Aurora Cannabis (ACB -1.64%) are down by 10.6%. Also down are shares of Cronos Group (CRON 0.00%) (11.6%), HEXO (HEXO -0.35%) (11.1%), OrganiGram Holdings (OGI -0.96%) (11.1%), and Tilray (TLRY) (12%). That's a lot of red ink, to be sure, especially for an industry that's already taken a huge step backward over the past 12 months. 

A young woman with a look of shock on her face.

Image source: Getty Images.

So what

The key concern seems to be the potential impact of COVID-19 on the global manufacturing supply chain. At the moment, nearly all vape products are manufactured in China, which also just happens to be the country hit hardest by this deadly respiratory ailment. 

The big deal is that Aurora, Cronos, HEXO, OrganiGram, and Tilray were all banking on high-margin derivative products like vape pens to be a major source of revenue growth in the months and years ahead. Now, it's not entirely clear whether any of these companies will be able to meet the demand for these products during the initial rollout of Cannabis 2.0, thanks to the anticipated disruption in the global supply chain due to COVID-19.

Now what

This latest double-digit drop might turn out to be particularly bad news for Aurora Cannabis and HEXO. Both of these companies now have share prices that are painfully close to violating the minimum bid requirements of the New York Stock Exchange (NYSE) after today's hefty drop. Simply put, Aurora and HEXO need to rebound soon; otherwise, these two pot companies might have to consider a dreaded reverse split in order to remain in compliance with NYSE listing rules.

On the bright side, Cronos, OrganiGram, and Tilray each has a fairly decent buffer in terms of their price per share. So a reverse split shouldn't be much of a concern for shareholders of these three cannabis companies. That being said, the whole market is going through a period of panic-selling over this viral threat, meaning that bargain hunters may want to remain on the sidelines with all of these names today. 

George Budwell owns shares of Cronos Group Inc. and OrganiGram Holdings. The Motley Fool owns shares of and recommends OrganiGram Holdings. The Motley Fool recommends HEXO. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
$1.20 (-1.64%) $0.02
Cronos Group Stock Quote
Cronos Group
$2.86 (0.00%) $0.00
OrganiGram Holdings Stock Quote
OrganiGram Holdings
$0.89 (-0.96%) $0.01
HEXO Stock Quote
$0.17 (-0.35%) $0.00
Tilray Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.